Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.70 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 2/20 | 0.45 |
| ▸ | RET | P07949 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.44 |
| ▸ | PNMT | P11086 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzylamine SCHEMBL7398997 | 0.91 | LOXL2 (0.64) | LOXL2TAAR1TSHRMAOBCYP1A2 | |
| SCHEMBL24465564 | 0.89 | LOXL2 (0.54) | LOXL2TAAR1TSHRHTR2ARET | |
| Benzylamine SCHEMBL373 | 0.84 | — | — | |
| Benzylamine SCHEMBL10707644 | 0.84 | LOXL2 (1.00) | LOXL2TAAR1TSHRMAOBCYP1A2 | |
| SCHEMBL19242392 | 0.84 | LOXL2 (1.00) | LOXL2TAAR1TSHRMAOBCYP1A2 | |
| Benzylamine SCHEMBL1331207 | 0.84 | — | — | |
| Benzylamine SCHEMBL5481672 | 0.84 | LOXL2 (1.00) | LOXL2TAAR1TSHRMAOBCYP1A2 | |
| Benzylamine SCHEMBL4306051 | 0.81 | — | — | |
| Benzylamine SCHEMBL20357787 | 0.81 | — | — | |
| Benzylamine SCHEMBL465924 | 0.81 | LOXL2 (0.93) | LOXL2TAAR1TSHRMAOBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190225889-A1 | METHOD TO EXTRACT BITUMEN FROM OIL SANDS USING AROMATIC AMINES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-25 | — | — | US | claimed |
| WO-2018111342-A1 | AMINE COMPOSITION FOR STEAM EXTRACTION OF BITUMEN | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-21 | — | — | WO | claimed |
| WO-2018017221-A1 | METHOD TO EXTRACT BITUMEN FROM OIL SANDS USING AROMATIC AMINES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-01-25 | — | — | WO | claimed |
| US-9090736-B2 | Rheological agent for radiation-curable coating compositions | BASF SE (DE) | 2015-07-28 | — | — | US | claimed |
| EP-2678364-B1 | RHEOLOGICAL AGENT FOR RADIATION-CURABLE COATING MATERIALS | BASF SE (DE) | 2015-04-08 | — | — | EP | claimed |
| US-20120214894-A1 | RHEOLOGICAL AGENT FOR RADIATION-CURABLE COATING COMPOSITIONS | BASF SE (DE) | 2012-08-23 | — | — | US | claimed |
| US-4357342-A | 1-Azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylic acid | MERCK & CO., INC. (US) | 1982-11-02 | — | — | US | claimed |
| EP-4682141-A1 | TRICYCLIC COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20250188023-A1 | BENZENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-06-12 | — | — | US | disclosed |
| US-12258308-B2 | Benzene derivative | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-03-25 | — | — | US | disclosed |
| US-20240327342-A1 | COMPOUNDS HAVING S1P5 RECEPTOR AGONISTIC ACTIVITY | ONO PHARMACEUTICAL CO., LTD. (JP) | 2024-10-03 | — | — | US | disclosed |
| EP-4431157-A2 | 1-[[(3S)-3-METHYL-6-(4(4,4-TRIFLUOROBUTOXY)-3,4-DIHYDRONAPHTHALEN-2YL]METHYL]AZETIDINE-3-CARBOXYLIC ACID HAVING S1P5 RECEPTOR AGONIST ACTIVITY FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS AND CANCER | ONO Pharmaceutical Co., Ltd. (JP) | 2024-09-18 | — | — | EP | disclosed |
| US-12049445-B2 | Compounds having S1P5 receptor agonistic activity | ONO PHARMACEUTICAL CO., LTD. (JP) | 2024-07-30 | — | — | US | disclosed |
| EP-0134301-A1 | 6-(1'-Hydroxyethyl)-3-substituted amino-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid | MERCK & CO. INC. (US) | 1985-03-20 | — | — | EP | disclosed |
| US-4424230-A | CARBAPENICILLIN ANTIBIOTICS | MERCK & CO., INC. (US) | 1984-01-03 | — | — | US | disclosed |
| EP-0071395-A1 | Beta-lactam antibacterial agents | BEECHAM GROUP PLC (GB) | 1983-02-09 | — | — | EP | disclosed |
| US-4369187-A | AMINO ACID DERIVATIVE ANTIBIOTICS | MERCK & CO., INC. (US) | 1983-01-18 | — | — | US | disclosed |
| US-4357342-A | 1-Azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylic acid | MERCK & CO., INC. (US) | 1982-11-02 | — | — | US | disclosed |
| EP-0055062-A1 | Compounds containing beta-lactams | BEECHAM GROUP PLC (GB) | 1982-06-30 | — | — | EP | disclosed |
| US-4310538-A | BACTERICIDES | MERCK & CO., INC. (US) | 1982-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12049445-B2 | Compounds having S1P5 receptor agonistic activity | S1PR5, S1PR1, S1PR4 | LOXL2 2283/4885TAAR1 235/4885TSHR 625/4885 |
| US-12258308-B2 | Benzene derivative | PMP22, TMBIM6, MYT1 | LOXL2 3622/4885TAAR1 3233/4885TSHR 4497/4885 |
| US-20240327342-A1 | COMPOUNDS HAVING S1P5 RECEPTOR AGONISTIC ACTIVITY | S1PR5, S1PR1, S1PR4 | LOXL2 2283/4885TAAR1 235/4885TSHR 625/4885 |
| US-20250188023-A1 | BENZENE DERIVATIVE | PMP22, TMBIM6, MYT1 | LOXL2 3710/4885TAAR1 3232/4885TSHR 4501/4885 |
| US-20120214894-A1 | RHEOLOGICAL AGENT FOR RADIATION-CURABLE COATING COMPOSITIONS | RAD51, XRCC6, XRCC5 | LOXL2 3457/4885TAAR1 3042/4885TSHR 4087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.